gvtcx

Provision of Fasudil Hydrochloride Capsules

University of Exeter Published 23 Nov 2021 Contracts Finder

key details

Value£500,000
Statuscomplete
Category (CPV) 33000000
RegionSouth West
Deadline16 Aug 2021
Procedureopen
OCIDocds-h6vhtk-02c838

Awards (2)

This procurement was awarded to 1 suppliers. Values shown are per-award; the notice total is £500,000.

SupplierValueDateStatus
Patheon UK Limited £815,555 11 Oct 2021 active
Patheon UK Limited · · active

description

The University of Exeter requires an end-to-end solution for Fasudil Hydrochloride Capsules. The product will be used as clinical supply for a Phase IIa study. The clinical trial will likely be conducted in the USA and/or Europe (United Kingdom and Norway), therefore all formulation components and finished product must meet the regulatory requirements of USP/EP/BP and any required Norwegian pharmacopeia standards. The supplier must also comply with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) and ensure that all supplies are released for clinical use by a duly certified Quality Person (QP).

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

4 notices published against this procurement.

PublishedTypeRegimeNotice
15 Jul 2021 Contract notice (F02) Earlier regulations 016582-2021
15 Jul 2021 Tender (tender) · bb2f877e-944a-4dc0-9d95-7ff401ff9a73-451729
23 Nov 2021 Contract award notice (F03) Earlier regulations 029136-2021
23 Nov 2021 Award (award) · 152f6f7e-e392-48c3-b34a-a4399e33befd-488070

more from University of Exeter

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.